[1]谈世刚,鲁汉杰,余 挺,等.不同异丙酚诱导麻醉对颅内假性动脉瘤介入治疗气管插管期心血管反应的影响[J].中国临床神经外科杂志,2019,(04):218-220.[doi:10.13798/j.issn.1009-153X.2019.04.009]
 TAN Shi-gang,LU Han-jie,YU Ting,et al.Effects of anesthesia induction with different methods of infusion of propofol on cardiovascular response in patients with pseudoaneurysms during tracheal intubation[J].,2019,(04):218-220.[doi:10.13798/j.issn.1009-153X.2019.04.009]
点击复制

不同异丙酚诱导麻醉对颅内假性动脉瘤介入治疗气管插管 期心血管反应的影响()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2019年04期
页码:
218-220
栏目:
论著
出版日期:
2019-04-27

文章信息/Info

Title:
Effects of anesthesia induction with different methods of infusion of propofol on cardiovascular response in patients with pseudoaneurysms during tracheal intubation
文章编号:
1009-153X(2019)04-0218-03
作者:
谈世刚鲁汉杰余 挺甘国胜宋晓阳
430070 武汉,中国人民解放军中部战区总医院麻醉科(谈世刚、鲁汉杰、余 挺、甘国胜、宋晓阳)
Author(s):
TAN Shi-gang LU Han-jie YU Ting GAN Guo-sheng SONG Xiao-yang.
Department of Anesthesia, General Hospital, Central Theater of the Chinese people’s Liberation Army, Wuhan 430070, China
关键词:
颅内假性动脉瘤介入治疗麻醉诱导异丙酚靶控输注气管插管
Keywords:
Intracranial pseudoaneurysms Different infusion Interventional therapy Tracheal intubation Induction anesthesia
分类号:
R 743.9; R 614.2
DOI:
10.13798/j.issn.1009-153X.2019.04.009
文献标志码:
A
摘要:
目的 观察异丙酚不同输注法行麻醉诱导对颅内假性动脉瘤介入治疗气管插管期心血管反应的影响。方法 选择2010年6月至2018年5月血管内介入治疗的颅内假性动脉瘤60例,根据麻醉诱导方 法分为三组:单次静脉推注组(A组)、血浆靶控组(B组)和效应室靶控组(C组),每组20例。麻醉诱导方法:A组采用异丙酚2 mg/kg单次静脉推注;B组设定异丙酚血浆靶浓度为4 μg/ml;C组设定异 丙酚效应室靶浓度4 μg/ml。三组均同时采用瑞芬太尼4 ng/ml血浆靶浓度靶控输注诱导,待意识消失后静注罗库溴铵0.6 mg/kg,脑电双频谱指数在40~60并维持5s时行气管插管。记录进入手术室(T0) 、喉镜暴露声门(T1)、气管导管过声门(T2)、气管导管进入气管后1 min(T3)、2 min(T4)、3 min(T5)平均动脉压(MAP)、心率(HR);并记录气管插管期不良反应及纠正次数。结果 与T0比 较,三组T1~T3 MAP均明显降低(P<0.05),三组T1~T5 HR均明显减慢(P<0.05);与B组比较,A组与C组T1 MAP明显降低(P<0.05)、HR明显减慢(P<0.05)。B组低血压、心动过缓等发生率和纠正次数 明显少于A组(P<0.05),而且B组心动过缓发生率和纠正次数少于C组(P<0.05)。C组纠正次数明显少于A组(P<0.05)。结论 4 μg/ml异丙酚血浆药物浓度作为目标靶控输注浓度更适合颅内假性动脉 瘤介入治疗的麻醉诱导,低血压和心动过缓不良反应等发生率更低。
Abstract:
Objective To observe the effect of anesthesia induction with different methods of infusion of propofol on cardiovascular response during endotracheal intubation during interventional therapy in patients with intracranial pseudoaneurysms. Methods Sixty patients with intracranial pseudoaneurysm undergoing interventional therapy were divided into three groups of 20 patients each, i.e. in group A (single intravenous injection of propofol), group B (target-controlled plasma concentration of propofol: 4 μg/ml) and group C (target-controlled effect site concertration: 4 μg/ml). All three groups anesthesia were induced by target-controlled infusion of remifentanil (target-controlled plasma concentration was 4 ng/ml) in all the groups. Rocuronium 0.6 mg/kg was injected intravenously after the patient’s consciousness disappeared. Tracheal intubation was performed when the bispectral index kept between 40 and 60 for 5 seconds. The mean arterial pressure (MAP) and heart rate (HR) were recorded at the time of entering the operating room (T0), immediately after exposure of the glottis with laryngoscope (T1), immediately after tracheal tube passing through the glottis (T2) and 1 minute (T3), 2 minutes (T4) and 3 minutes (T5) after tracheal tube entering the trachea the incidence and correction times of adverse reactions during tracheal intubation were recorded. Results MAP significantly decreased at T1, T2 and T3, HR slowed significantly at T1, T2, T3, T4 and T5 in all the groups (P<0.05) compared with those at T0. MAP was significantly lower and HR was significantly slower in groups A and C than those in group B at T1 (P<0.05). The incidences of hypotension and bradycardia and the number of their correction in group B were significantly lower than those in group A (P<0.05) and the number of correction in group C was significantly lower than that in group A (P<0.05). The incidence and number of correction of bradycardia in group B were significantly lower than those in group C (P<0.05). Conclusions The plasma concentration of 4 μg/ml propofol as the target-controlled infusion concentration is more suitable for anesthesia induction in patients with intracranial pseudoaneurysms undergoing interventional therapy, and the incidence of the adverse reactions including hypotension and bradycardia is significantly lower.

参考文献/References:

[1] 李 彤,孙永全,顾 征. 伤性颅内假性动脉瘤的血管内 治疗[J]. 中华神经外科杂志,2016,32(7):696-700.
[2] 赵明珠,Sugie Akira,刘卫东,等.手术治疗大脑前动脉远 端外伤性假性动脉瘤[J]. 中国临床神经外科杂志,2010, 15(10):594-596.
[3] 张国楼. 全插管期心血管副反应的防治[J]. 临床麻醉学, 2001,17(12):673.
[4] Sheinner LB, Stanski DR, Vozeh S, et al. Simultaneous modeling of pharmacokinetcs and pharmacodynamics: application to d-tubocurarine [J]. Clin pharmacol Ther, 1979, 25(3): 358-371.
[5] Paiva, WS, de Andrade, AF, Amorim, RL, et al. Traumatic pseudoaneurysm of the middle meningeal artery causing an intracerebral hemorrhage [J]. Case Rep Med, 2010, 2010: 219572
[6] Dubey A, Sung WS, Chen YY, et al. Trumaatic intracranial aneurysm: a brief review [J]. J Clin Neurosci, 2008, 15(6): 609-612.
[7] 邵 伟,毕严斌,班延林,等. 丙泊酚靶控输入诱导复合小 剂量雷米芬太尼[J]. 山东医药,2005,45(26):49-50.
[8] 刘永勤,李 鹏,赵海涛,等. 不同麻醉药物对老年人全麻 术中血流动力学影响的观察[J]. 人民军医,2013,56 (10):1174-1175.
[9] Mertens MJ, Olofsen E, Engbers FH, et al. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remi- fentanil-propofol interactions [J]. Anesthesiology, 2003, 99 (2): 347-359.
[10] 童 博,杨宗林,郑荣芝,等. 不同剂量丙泊酚用于复合麻 醉诱导对循环系统影响的观察[J]. 人民军医,2012,55 (10):964-965.
[11] 梁启胜,杨茗竣,符 炜,等. 脑电双频指数指导下丙泊 酚,舒芬太尼联合靶控对冠状动脉旁路移植术麻醉诱导 期血流动力学影响[J]. 蚌埠医学院学报,2012 ,37(10): 1155-1158.
[12] 易 杰,叶铁虎,罗爱伦,等. 两种靶控方法输注异丙酚和 瑞芬太尼的安全性和有效性比较[J]. 中华麻醉学杂志, 2004,24(3):183-186.
[13] Trabold F, Casetta J, Duranteau P, et al. Propofol and remi- fentanil for intubation without muscle relaxant: the effect of the order of injection [J]. Acta Anaesthesiol Scand, 2004, 48 (1): 35-39.

相似文献/References:

[1]王 丽 华 莎 束 枫.Onyx胶和Glubran胶在脑血管病介入治疗中使用的配合[J].中国临床神经外科杂志,2015,(11):696.[doi:10.13798/j.issn.1009-153X.2015.11.019]
[2]易汉娥 乐革芬 詹昱新 刘 恒 吕 珉 赵沃华 胡学兵 冯 军.神经介入治疗工作人员辐射防护存在的问题与对策[J].中国临床神经外科杂志,2015,(09):565.[doi:10.13798/j.issn.1009-153X.2015.09.021]
[3]高 涢 田春雷 综述 王雄伟 审校.创伤性胼周动脉动脉瘤的诊断与治疗[J].中国临床神经外科杂志,2017,(05):360.[doi:10.13798/j.issn.1009-153X.2017.05.029]
[4]李东蛟 徐兴国 万 定 兰朋朋 杨振兴 冯 进 黄德俊 李宗正.颅内破裂微小动脉瘤介入治疗预后的危险因素分析[J].中国临床神经外科杂志,2018,(04):232.[doi:10.13798/j.issn.1009-153X.2018.04.003]
 LI Dong-jiao,XU Xing-guo,WAN Ding,et al.Analysis of risk factors related to prognoses in patients with intracranial ruptured tiny aneurysms treated by interventional therapy[J].,2018,(04):232.[doi:10.13798/j.issn.1009-153X.2018.04.003]
[5]宋 平 罗 明 王 远 黄从刚 李继强 丁 伟 王孟阳 段发亮.经股动脉介入术后致假性动脉瘤2例[J].中国临床神经外科杂志,2018,(04):304.[doi:10.13798/j.issn.1009-153X.2018.04.030]
[6]于爱侠 孙晓兰 单 瑞 张芳兰.整体性护理在脑动脉瘤早期介入治疗中的应用[J].中国临床神经外科杂志,2019,(02):117.[doi:10.13798/j.issn.1009-153X.2019.02.018]
[7]李矜玥 张雪梅.急性脑缺血卒中串联性脑动脉闭塞的介入治疗[J].中国临床神经外科杂志,2019,(05):317.[doi:10.13798/j.issn.1009-153X.2019.05.022]
[8]李莉华 华 莎 王 红.脊髓静脉高压综合征手术或介入治疗围手术期的护理[J].中国临床神经外科杂志,2019,(07):439.[doi:10.13798/j.issn.1009-153X.2019.07.022]
[9]李治国 水少锋 韩新巍 闫 磊 马 骥 郭 栋 李腾飞 袁慧锋.颈内动脉多发宽颈动脉瘤的介入治疗分析[J].中国临床神经外科杂志,2019,(08):453.[doi:10.13798/j.issn.1009-153X.2019.08.002]
 LI Zhi-guo,SHUI Shao-feng,HAN Xin-wei,et al.Analysis of stent-assisted intervenient treatment of multiple wide-necked aneurysms of internal carotid arteries[J].,2019,(04):453.[doi:10.13798/j.issn.1009-153X.2019.08.002]
[10]谈世刚 鲁汉杰 宋晓阳.右美托咪定滴鼻对老年颅内动脉瘤栓塞全麻插管期脑血流动力学的影响[J].中国临床神经外科杂志,2019,(09):537.[doi:10.13798/j.issn.1009-153X.2019.09.008]
 TAN Shi-gang,LU Han-jie,SONG Xiao-yang.Effect of intranasal administration of dexmedetomidine on cerebral hemodynamics during general anesthesia in elderly patients with cerebral aneurysms undergoing intervenient therapy[J].,2019,(04):537.[doi:10.13798/j.issn.1009-153X.2019.09.008]

备注/Memo

备注/Memo:
(2018-09-27收稿,2019-02-02修回) 通讯作者:甘国胜,E-mail:526193186@qq.com 页码220+223
更新日期/Last Update: 2019-04-27